Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioid antagonist impedes exposure.

T V Merluzzi1, C B Taylor, M Boltwood

  • 1University of Notre Dame.

Journal of Consulting and Clinical Psychology
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of self-efficacy for caregiving in oncology: Italian validation of the caregiver inventory (CGI-I).

BMC palliative care·2021
Same author

Obesity prevention in defined (high school) populations.

International journal of obesity supplements·2014
Same author

Childhood abuse history in older women with panic disorder.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2011
Same author

Somatization: the under-recognized factor in nonspecific eczema. The Hordaland Health Study (HUSK).

The British journal of dermatology·2010
Same author

Loss of available phosphate in soil due to micro-organisms.

Nature·2010
Same author

Severe falciparum malaria patients transferred "late" to a high level ICU in India represents a difficult research capture point to comment on predictors of mortality and related organ dysfunction.

Singapore medical journal·2010

Exposure therapy for phobias may involve endorphins. Blocking these with naltrexone (an opioid antagonist) led to more dropouts and slower progress in spider-phobic individuals during exposure treatment.

Area of Science:

  • Psychology
  • Neuroscience
  • Pharmacology

Background:

  • Exposure therapy is a recognized treatment for simple phobias.
  • The role of endogenous opioid system in phobia treatment is not fully understood.

Purpose of the Study:

  • To investigate the involvement of endorphin release in exposure therapy for spider phobia.
  • To examine the effects of naltrexone, an opioid antagonist, on exposure treatment outcomes.

Main Methods:

  • Thirty participants with spider phobia underwent graded exposure tasks.
  • Participants were randomly assigned to receive either naltrexone or a placebo.
  • Physiological (heart rate, blood pressure) and psychological (anxiety, self-efficacy, cognitions) measures were collected.

Related Experiment Videos

Main Results:

  • The naltrexone group exhibited significantly higher dropout rates and took longer to complete treatment steps.
  • Participants receiving naltrexone showed greater maximum heart rate and anxiety levels at a key treatment point.
  • No significant differences were observed in self-efficacy or cognitive measures between groups.

Conclusions:

  • Findings suggest the endogenous opioid system plays a role in the efficacy of exposure therapy.
  • Opioid system modulation may impact treatment adherence and symptom reduction during exposure.